Quantitative changes in endogenous DNA adducts correlate with conazole in vivo mutagenicity and tumorigenicity

Mutagenesis

Volumn 27, Issue 5, 2012, Pages 541-549

  Ross, Jeffrey A ^a   Leavitt, Sharon A ^a   Schmid, Judith E ^a   Nelson, Garret B ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCLOBUTANIL; PHOSPHORUS 32; PROPICONAZOLE; TRIADIMEFON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; DNA ADDUCT; DNA SEQUENCE; GENE MUTATION; LIVER TUMOR; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DNA ADDUCTS; LIVER; MALE; MICE; MUTAGENS; MUTATION; TRIAZOLES;

EID: 84864839914     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ges017     Document Type: Article

References (84)

1. Lambert, I. B., Singer, T. M., Boucher, S. E. and Douglas, G. R. (2005) Detailed review of transgenic rodent mutation assays. Mutat. Res., 590, 1-280.
2. Leavitt, S. A., George, M. H., Moore, T. and Ross, J. A. (2008) Mutations induced by benzo[a]pyrene and dibenzo[a, l]pyrene in lacI transgenic B6C3F1 mouse lung result from stable DNA adducts. Mutagenesis, 23, 445-50.
3. Ross, J. A. and Leavitt, S. A. (1998) Induction of mutations by 2- acetylaminofluorene in lacI transgenic B6C3F1 mouse liver. Mutagenesis, 13, 173-179.
4. Deutsch, W. A., Kukreja, A., Shane, B. and Hegde, V. (2001) Phenobarbital, oxazepam and Wyeth 14, 643 cause DNA damage as measured by the Comet assay. Mutagenesis, 16, 439-442.
5. Gunz, D., Shephard, S. E. and Lutz, W. K. (1993) Can nongenotoxic carcinogens be detected with the lacI transgenic mouse mutation assay? Environ. Mol. Mutagen., 21, 209-211.
6. Umemura, T., Kuroiwa, Y., Tasaki, M. et al. (2007) Detection of oxidative DNA damage, cell proliferation and in vivo mutagenicity induced by dicyclanil, a non-genotoxic carcinogen, using gpt delta mice. Mutat. Res., 633, 46-54.
7. INCHEM (1981) Monograph 566. Triadimefon (Pesticide Residues in Food: 1981 Evaluations). http://www.inchem.org/documents/jmpr/jmpmono/v81pr32.htm (accessed March 29, 2012).
8. INCHEM (1987) Monograph 768. Propiconazole (Pesticide Residues in Food: 1987 Evaluations. Part II Toxicology). http://www.inchem.org/documents/jmpr/ jmpmono/v87pr13.htm (accessed March 29, 2012).
9. US Environmental Protection Agency (1996) Triadimefon; pesticide tolerances for emergency exemptions. Fed. Reg., 61, 63721-63726.
10. US Environmental Protection Agency (2004) Propiconazole; time-limited pesticide tolerances. Fed. Reg., 62, 47005-47013.
11. INCHEM (1992) Monograph 847 Myclobutanil (Pesticide Residues in Food: 1992 Evaluations. Part II: Toxicology). http://www.inchem.org/documents/jmpr/ jmpmono/v92pr13.htm (accessed March 29, 2012).
12. US Environmental Protection Agency (2000) Myclobutanil; pesticide tolerances. Fed. Reg., 65, 29963-29973.
13. Ross, J. A., Moore, T. and Leavitt, S. A. (2009) In vivo mutagenicity of conazole fungicides correlates with tumorigenicity. Mutagenesis, 24, 149-152.
14. Ross, J. A. and Leavitt, S. A. (2010) Analysis of the mutations induced by conazole fungicides in vivo. Mutagenesis, 25, 231-234.
15. Nesnow, S., Padgett, W. T. and Moore, T. (2011) Propiconazole induces alterations in the hepatic metabolome of mice: relevance to propiconazoleinduced hepatocarcinogenesis. Toxicol. Sci., 120, 297-309.
16. Nesnow, S., Ward, W., Moore, T., Ren, H. and Hester, S. D. (2009) Discrimination of tumorigenic triazole conazoles from phenobarbital by transcriptional analyses of mouse liver gene expression. Toxicol. Sci., 110, 68-83.
17. Ward, W. O., Delker, D. A., Hester, S. D., Thai, S. F., Wolf, D. C., Allen, J. W. and Nesnow, S. (2006) Transcriptional profiles in liver from mice treated with hepatotumorigenic and nonhepatotumorigenic triazole conazole fungicides: propiconazole, triadimefon, and myclobutanil. Toxicol. Pathol., 34, 863-878.
18. Bruno, M., Moore, T., Nesnow, S. and Ge, Y. (2009) Protein carbonyl formation in response to propiconazole-induced oxidative stress. J. Proteome Res., 8, 2070-2078.
19. Ortiz, P. A., Bruno, M. E., Moore, T., Nesnow, S., Winnik, W. and Ge, Y. (2010) Proteomic analysis of propiconazole responses in mouse liver: comparison of genomic and proteomic profiles. J. Proteome Res., 9, 1268-1278.
20. Nesnow, S., Grindstaff, R., Lambert, G., Padgett, W. T., Bruno, M., Ge, Y., Chen, P. J., Wood, C. E. and Murphy, L. (2011) Propiconazole increases reactive oxygen species levels in mouse hepatic cells in culture and in mouse liver by a cytochrome P450 enzyme mediated process. Chem. Biol. Interact, 194, 79-89.
21. Gupta, R. C. and Spencer-Beach, G. (1996) Natural and endogenous DNA adducts as detected by 32P-postlabeling. Regul. Toxicol. Pharmacol., 23, 14-21.
22. Ravoori, S., Vadhanam, M. V., Davey, D. D., Srinivasan, C., Nagarajan, B. and Gupta, R. C. (2006) Modulation of novel DNA adducts during human uterine cervix cancer progression. Int. J. Oncol., 29, 1437-1443.
23. Aiyer, H. S., Kichambare, S. and Gupta, R. C. (2008) Prevention of oxidative DNA damage by bioactive berry components. Nutr Cancer, 60 (Suppl. 1), 36-42.
24. Aiyer, H. S., Srinivasan, C. and Gupta, R. C. (2008) Dietary berries and ellagic acid diminish estrogen-mediated mammary tumorigenesis in ACI rats. Nutr. Cancer, 60, 227-234.
25. Aiyer, H. S., Vadhanam, M. V., Stoyanova, R., Caprio, G. D., Clapper, M. L. and Gupta, R. C. (2008) Dietary berries and ellagic acid prevent oxidative DNA damage and modulate expression of DNA repair genes. Int. J. Mol. Sci., 9, 327-341.
26. Gupta, R. C., Arif, J. M. and Gairola, C. G. (1999) Enhancement of preexisting DNA adducts in rodents exposed to cigarette smoke. Mutat. Res., 424, 195-205.
27. Ravoori, S., Ayotte, P., Srinivasan, C., Pereg, D., Robertson, L. W., Russell, G. K., Jeyabalan, J. and Gupta, R. C. (2008) DNA damage associated with PCBs in the whole blood cells of Inuit. Environ. Toxicol. Pharmacol., 25, 273-276.
28. Ravoori, S., Feng, Y., Neale, J. R., Jeyabalan, J., Srinivasan, C., Hein, D. W. and Gupta, R. C. (2008) Dose-dependent reduction of 3, 2#- dimethyl-4-aminobiphenyl-derived DNA adducts in colon and liver of rats administered celecoxib. Mutat. Res., 638, 103-109.
29. Allen, J. W., Wolf, D. C., George, M. H. et al. (2006) Toxicity profiles in mice treated with hepatotumorigenic and non-hepatotumorigenic triazole conazole fungicides: propiconazole, triadimefon, and myclobutanil. Toxicol. Pathol., 34, 853-862.
30. Ross, J. A., Nelson, G. B. and Holden, K. L. (1991) DNA isolation from small tissue samples using salt and spermine. Nucleic Acids Res., 19, 6053.
31. Ross, J., Nelson, G., Erexson, G., Kligerman, A., Earley, K., Gupta, R. C. and Nesnow, S. (1991) DNA adducts in rat lung, liver and peripheral blood lymphocytes produced by i.p. administration of benzo[a]pyrene metabolites and derivatives. Carcinogenesis, 12, 1953-1955.
32. Prahalad, A. K., Ross, J. A., Nelson, G. B., Roop, B. C., King, L. C., Nesnow, S. and Mass, M. J. (1997) Dibenzo[a, l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. Carcinogenesis, 18, 1955-1963.
33. Jawich, D., Lteif, R., Pfohl-Leszkowicz, A. and Strehaiano, P. (2006) Effects of penconazole on two yeast strains: growth kinetics and molecular studies. Mol. Nutr. Food Res., 50, 552-556.
34. Faucet, V., Pfohl-Leszkowicz, A., Dai, J., Castegnaro, M. and Manderville, R. A. (2004) Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem. Res. Toxicol., 17, 1289-1296.
35. Nelson, G. B. and Ross, J. A. (1998) DNA adduct formation by the pesticide alachlor and its metabolite 2-chloro-N-(2, 6-diethylphenyl)acetamide (CDEPA). Bull Environ. Contam. Toxicol., 60, 387-394.
36. Lewis, P. D., Manshian, B., Routledge, M. N., Scott, G. B. and Burns, P. A. (2008) Comparison of induced and cancer-associated mutational spectra using multivariate data analysis. Carcinogenesis, 29, 772-778.
37. Leavitt, S. A., DeAngelo, A. B., George, M. H. and Ross, J. A. (1997) Assessment of the mutagenicity of dichloroacetic acid in lacI transgenic B6C3F1 mouse liver. Carcinogenesis, 18, 2101-2116.
38. Randerath, K., Randerath, E., Zhou, G. D. and Li, D. (1999) Bulky endogenous DNA modifications (I-compounds) - possible structural origins and functional implications. Mutat. Res., 424, 183-194.
39. Carmichael, N. G., Enzmann, H., Pate, I. and Waechter, F. (1997) The significance of mouse liver tumor formation for carcinogenic risk assessment: results and conclusions from a survey of ten years of testing by the agrochemical industry. Environ. Health Perspect., 105, 1196-1-203.
40. Fernandes, A., Liu, T., Amin, S., Geacintov, N. E., Grollman, A. P. and Moriya, M. (1998) Mutagenic potential of stereoisomeric bay region (+)- and (-)-cis-anti-benzo[a]pyrene diol epoxide-N2-2#-deoxyguanosine adducts in Escherichia coli and simian kidney cells. Biochemistry, 37, 10164-10172.
41. Lambert, I. B., Chin, T. A., Bryant, D. W., Gordon, A. J., Glickman, B. W. and McCalla, D. R. (1991) The mutational specificity of 2-(2-furyl)-3-(5- nitro-2-furyl)-acrylamide (AF2) in the lacI gene of Escherichia coli. Carcinogenesis, 12, 29-34.
42. Lasko, D. D., Harvey, S. C., Malaikal, S. B., Kadlubar, F. F. and Essigmann, J. M. (1988) Specificity of mutagenesis by 4-aminobiphenyl. A possible role for N-(deoxyadenosin-8-yl)-4-aminobiphenyl as a premutational lesion. J. Biol. Chem., 263, 15429-15435.
43. Malia, S. A. and Basu, A. K. (1995) Mutagenic specificity of reductively activated 1-nitropyrene in Escherichia coli. Biochemistry, 34, 96-104.
44. Moriya, M., Spiegel, S., Fernandes, A., Amin, S., Liu, T., Geacintov, N. and Grollman, A. P. (1996) Fidelity of translesional synthesis past benzo[a]pyrene diol epoxide-2#-deoxyguanosine DNA adducts: marked effects of host cell, sequence context, and chirality. Biochemistry, 35, 16646-16651.
45. Roche, C. J., Jeffrey, A. M., Mao, B., Alfano, A., Kim, S. K., Ibanez, V. and Geacintov, N. E. (1991) Dependence of conformations of benzo[a]- pyrene diol epoxide-DNA adducts derived from stereoisomers of different tumorigenicities on base sequence. Chem. Res. Toxicol., 4, 311-317.
46. Rodriguez, H. and Loechler, E. L. (1993) Mutational specificity of the (+)-anti-diol epoxide of benzo[a]pyrene in a supF gene of an Escherichia coli plasmid: DNA sequence context influences hotspots, mutagenic specificity and the extent of SOS enhancement of mutagenesis. Carcinogenesis, 14, 373-383.
47. Ross, J. A. and Nesnow, S. (1999) Polycyclic aromatic hydrocarbons: correlations between DNA adducts and ras oncogene mutations. Mutat. Res., 424, 155-156.
48. Simhadri, S., Kramata, P., Zajc, B., Sayer, J. M., Jerina, D. M., Hinkle, D. C. and Wei, C. S. (2002) Benzo[a]pyrene diol epoxidedeoxyguanosine adducts are accurately bypassed by yeast DNA polymerase zeta in vitro. Mutat. Res., 508, 137-145.
49. Yuan, W., Kiselyov, A. S., Harvey, R. G. and Carothers, A. M. (1995) Mutagenic specificity of syn-benzo[g]chrysene 11, 12-dihydrodiol 13, 14- epoxide in the dihydrofolate reductase gene of Chinese hamster ovary cells. Carcinogenesis, 16, 2869-2873.
50. Broschard, T. H., Koffel-Schwartz, N. and Fuchs, R. P. (1999) Sequencedependent modulation of frameshift mutagenesis at NarI-derived mutation hot spots. J. Mol. Biol., 288, 191-199.
51. Burnouf, D. Y., Miturski, R. and Fuchs, R. P. (1999) Sequence context modulation of translesion synthesis at a single N-2-acetylaminofluorene adduct located within a mutation hot spot. Chem. Res. Toxicol., 12, 144-150.
52. Page, J. E., Zajc, B., Oh-hara, T., Lakshman, M. K., Sayer, J. M., Jerina, D. M. and Dipple, A. (1998) Sequence context profoundly influences the mutagenic potency of trans-opened benzo[a]pyrene 7, 8-diol 9, 10-epoxide-purine nucleoside adducts in site-specific mutation studies. Biochemistry, 37, 9127-9137.
53. Ponten, I., Sayer, J. M., Pilcher, A. S., Yagi, H., Kumar, S., Jerina, D. M. and Dipple, A. (1999) Sequence context effects on mutational properties of cis-opened benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts in site-specific mutation studies. Biochemistry, 38, 1144-1152.
54. Rodriguez, F. A., Cai, Y., Lin, C., Tang, Y., Kolbanovskiy, A., Amin, S., Patel, D. J., Broyde, S. and Geacintov, N. E. (2007) Exocyclic amino groups of flanking guanines govern sequence-dependent adduct conformations and local structural distortions for minor groove-aligned benzo[a]pyrenyl-guanine lesions in a GG mutation hotspot context. Nucleic Acids Res., 35, 1555-1568.
55. Ross, H., Bigger, C. A., Yagi, H., Jerina, D. M. and Dipple, A. (1993) Sequence specificity in the interaction of the four stereoisomeric benzo[c]phenanthrene dihydrodiol epoxides with the supF gene. Cancer Res., 53, 1273-1277.
56. Wang, H., Marnett, L. J., Harris, T. M. and Rizzo, C. J. (2004) A novel synthesis of malondialdehyde adducts of deoxyguanosine, deoxyadenosine, and deoxycytidine. Chem. Res. Toxicol., 17, 144-149.
57. Kohler, S. W., Provost, G. S., Fieck, A., Kretz, P. L., Bullock, W. O., Putman, D. L., Sorge, J. A. and Short, J. M. (1991) Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector. Environ. Mol. Mutagen., 18, 316-321.
58. Schaaper, R. M., Danforth, B. N. and Glickman, B. W. (1986) Mechanisms of spontaneous mutagenesis: an analysis of the spectrum of spontaneous mutation in the Escherichia coli lacI gene. J. Mol. Biol., 189, 273-284.
59. Hill, K. A., Buettner, V. L., Glickman, B. W. and Sommer, S. S. (1999) Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived. Mutat. Res., 436, 11-19.
60. de Boer, J. G., Erfle, H., Walsh, D., Holcroft, J., Provost, J. S., Rogers, B., Tindall, K. R. and Glickman, B. W. (1997) Spectrum of spontaneous mutations in liver tissue of lacI transgenic mice. Environ. Mol. Mutagen., 30, 273-286.
61. You, Y. H., Halangoda, A., Buettner, V., Hill, K., Sommer, S. and Pfeifer, G. (1998) Methylation of CpG dinucleotides in the lacI gene of the Big Blue transgenic mouse. Mutat. Res., 420, 55-65.
62. Skopek, T. R., Kort, K. L., Marino, D. R., Mittal, L. V., Umbenhauer, D. R., Laws, G. M. and Adams, S. P. (1996) Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice. Environ. Mol. Mutagen., 28, 376-384.
63. Skopek, T. R., Marino, D. R., Kort, K. L., Miller, J. and Pippert, T. (1996) Synthesis of a lacI gene analogue with reduced CpG content. Mutat. Res., 349, 163-172.
64. Boysen, G., Pachkowski, B. F., Nakamura, J. and Swenberg, J. A. (2009) The formation and biological significance of N7-guanine adducts. Mutat. Res., 678, 76-94.
65. Gupta, R. C. and Lutz, W. K. (1999) Background DNA damage for endogenous and unavoidable exogenous carcinogens: a basis for spontaneous cancer incidence? Mutat. Res., 424, 1-8.
66. Marnett, L. J. and Burcham, P. C. (1993) Endogenous DNA adducts: potential and paradox. Chem. Res. Toxicol., 6, 771-785.
67. Marnett, L. J. and Plastaras, J. P. (2001) Endogenous DNA damage and mutation. Trends Genet., 17, 214-221.
68. Morinello, E. J., Ham, A. J., Ranasinghe, A., Sangaiah, R. and Swenberg, J. A. (2001) Simultaneous quantitation of N(2), 3-ethenoguanine and 1, N(2)-ethenoguanine with an immunoaffinity/gas chromatography/high-resolution mass spectrometry assay. Chem. Res. Toxicol., 14, 327-334.
69. Mutlu, E., Collins, L. B., Stout, M. D., Upton, P. B., Daye, L. R., Winsett, D., Hatch, G., Evansky, P. and Swenberg, J. A. (2010) Development and application of an LC-MS/MS method for the detection of the vinyl chloride-induced DNA adduct N(2), 3-ethenoguanine in tissues of adult and weanling rats following exposure to [(13)C(2)]-VC. Chem. Res. Toxicol., 23, 1485-1491.
70. Swenberg, J. A., La, D. K., Scheller, N. A. and Wu, K. Y. (1995) Doseresponse relationships for carcinogens. Toxicol. Lett., 82-83, 751-756.
71. Yen, T. Y., Holt, S., Sangaiah, R., Gold, A. and Swenberg, J. A. (1998) Quantitation of 1, N6-ethenoadenine in rat urine by immunoaffinity extraction combined with liquid chromatography/electrospray ionization mass spectrometry. Chem. Res. Toxicol., 11, 810-815.
72. Moore, S. R., Hill, K. A., Heinmoller, P. W., Halangoda, A., Kunishige, M., Buettner, V. L., Graham, K. S. and Sommer, S. S. (1999) Spontaneous mutation frequency and pattern in Big Blue mice fed a vitamin E-supplemented diet. Environ. Mol. Mutagen., 34, 195-200.
73. Kunishige, M., Hill, K. A., Riemer, A. M., Farwell, K. D., Halangoda, A., Heinmoller, E., Moore, S. R., Turner, D. M. and Sommer, S. S. (2001) Mutation frequency is reduced in the cerebellum of Big Blue mice overexpressing a human wild type SOD1 gene. Mutat. Res., 473, 139-149.
74. Chen, P.-J., Padgett, W. T., Moore, T., Winnik, W., Lambert, G. R., Thai, S.-F., Hester, S. D. and Nesnow, S. (2009) Three conazoles increase hepatic microsomal retinoic acid metabolism and decrease mouse hepatic retinoic acid levels in vivo. Toxicol. Appl. Pharmacol., 234, 143-155.
75. Ross, J. A., Blackman, C. F., Thai, S. F., Li, Z., Kohan, M., Jones, C. P. and Chen, T. (2010) A potential microRNA signature for tumorigenic conazoles in mouse liver. Mol. Carcinog., 49, 320-323.
76. US Environmental Protection Agency (2005) Guidelines for carcinogen risk assessment. Fed. Reg., 70, 17765-17817.
77. US Environmental Protection Agency (2005) Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Carcinogens. EPA/630/R-03/003F, http://www.epa.gov/raf/publications/pdfs/CHILDRENS- SUPPLEMENT-FINAL-.PDF (accessed March 29, 2012).
78. Shane, B. S., deBoer, J. G., Glickman, B. W. and Cunningham, M. L. (1999) Oxazepam is mutagenic in vivo in Big Blue transgenic mice. Carcinogenesis, 20, 1315-1321.
79. Singh, V. K., Ganesh, L., Cunningham, M. L. and Shane, B. S. (2001) Comparison of the mutant frequencies and mutation spectra of three nongenotoxic carcinogens, oxazepam, phenobarbital, and Wyeth 14, 643, at the lambda cII locus in Big Blue transgenic mice. Biochem. Pharmacol., 62, 685-692.
80. Mirsalis, J. C., Monforte, J. A. and Winegar, R. A. (1994) Transgenic animal models for measuring mutations in vivo. Crit. Rev. Toxicol., 24, 255-280.
81. Shane, B. S., Lockhart, A. M., Winston, G. W. and Tindall, K. R. (1997) Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy. Mutat. Res., 377, 1-11.
82. Arai, T., Kelly, V. P., Komoro, K., Minowa, O., Noda, T. and Nishimura, S. (2003) Cell proliferation in liver of Mmh/Ogg1-deficient mice enhances mutation frequency because of the presence of 8- hydroxyguanine in DNA. Cancer Res., 63, 4287-4292.
83. Organisation for Economic Cooperation and Development (2011) OECD Guidelines for the Testing of Chemicals, Section 4, Test No. 488: Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays. OECD Publishing, Paris, France.
84. World Health Organization (2000) Toxicological evaluation of certain veterinary drug residues in food. World Health Organ. Food Additive Ser., 45, 75-89.